Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Organogenesis Holdings (ORGO) Cash from Operations: 2016-2025

Historic Cash from Operations for Organogenesis Holdings (ORGO) over the last 9 years, with Sep 2025 value amounting to $3.1 million.

  • Organogenesis Holdings' Cash from Operations fell 64.59% to $3.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$38.8 million, marking a year-over-year decrease of 379.38%. This contributed to the annual value of $14.2 million for FY2024, which is 54.04% down from last year.
  • Organogenesis Holdings' Cash from Operations amounted to $3.1 million in Q3 2025, which was up 109.37% from -$32.9 million recorded in Q2 2025.
  • In the past 5 years, Organogenesis Holdings' Cash from Operations registered a high of $27.9 million during Q3 2021, and its lowest value of -$32.9 million during Q2 2025.
  • Moreover, its 3-year median value for Cash from Operations was $4.7 million (2024), whereas its average is -$418,545.
  • As far as peak fluctuations go, Organogenesis Holdings' Cash from Operations spiked by 287.25% in 2021, and later slumped by 793.82% in 2025.
  • Organogenesis Holdings' Cash from Operations (Quarterly) stood at $17.9 million in 2021, then plummeted by 56.54% to $7.8 million in 2022, then soared by 36.08% to $10.6 million in 2023, then grew by 3.04% to $10.9 million in 2024, then slumped by 64.59% to $3.1 million in 2025.
  • Its Cash from Operations was $3.1 million in Q3 2025, compared to -$32.9 million in Q2 2025 and -$19.9 million in Q1 2025.